Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc.

VANCOUVER, British Columbia & MONTREAL--(BUSINESS WIRE)--Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the “Company”) by Versant Venture Capital VI, L.P., Versant Vantage I, L.P., Versant Venture Capital V, L.P., Versant Venture Capital V (Canada) LP, Versant Ophthalmic Affiliates Fund I, L.P. and Versant Affiliates Fund V, L.P. (collectively, the “Versant Funds”). On June 6, 2022, some of the Versa